Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has issued an update.
Shanghai HeartCare Medical Technology Corporation Limited has announced the convening of its 2025 second extraordinary general meeting (EGM) to be held on August 29, 2025. The primary agenda is to consider and approve the utilization of the company’s capital reserve to offset significant losses amounting to RMB575,082,245.74. This move is in accordance with the company’s Articles of Association and relevant laws, indicating a strategic financial decision aimed at stabilizing the company’s financial standing.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company based in the People’s Republic of China, specializing in medical technology. The company operates within the healthcare industry, focusing on developing and providing advanced medical solutions.
Average Trading Volume: 144,581
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.08B
Find detailed analytics on 6609 stock on TipRanks’ Stock Analysis page.